From Investing.com: 2024-05-18 19:21:50

Teknova (Ticker: TKNO) reported a 2% YoY increase in Q1 2024 revenue, with an 18% sequential improvement from Q4 2023. Cost management strategies led to a $2.3 million improvement in adjusted EBITDA. The company expects full-year revenue between $35 million and $38 million. Teknova’s diverse customer base and new product launches drive growth.

Teknova’s Q1 2024 earnings call highlighted positive revenue growth, cost management strategies, and guidance for the full year. The company remains optimistic about market conditions and its long-term success. Teknova’s focus on customer diversification, new product launches, and efficient cost management contribute to its steady growth and financial stability.

Teknova’s revenue growth of 2% YoY and 18% sequentially in Q1 2024 reflects the company’s ability to adapt and innovate. Cost management efforts resulted in a $2.3 million improvement in adjusted EBITDA. The company’s diverse customer base and new product offerings position it for continued success in the clinical and lab solutions market.



Read more at Investing.com: Teknova sees modest revenue growth in Q1 2024 By Investing.com